Skip to main content

UBS Group AG

Position in RZLT — Rezolute, Inc.

CIK 1610520 ZURICH, V8

Position in RZLT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$5,911,064
-$735,382 QoQ
Shares Held
1,938,054
-31.2% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. RZLT ranks #133 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RZLT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,911,064 1,938,054
2025-12-31 $6,646,446 2,816,291
2025-09-30 $25,342,193 2,695,978
2025-06-30 $13,545,769 3,037,168
2025-03-31 $1,787,893 616,515
2024-12-31 $1,625,815 331,799
2024-09-30 $9,908 2,043
2024-06-30 $15,540 3,614
2023-12-31 $216,376 217,902
2023-03-31 $3,947 2,056
2022-06-30 $5,622 1,741
2022-03-31 $15,179 4,491
2021-12-31 $20,592 4,308
2021-09-30 $27,455 3,671
2021-06-30 $13,099 918
2021-03-31 $4,123 584
2020-12-31 $11,342 946